CME credits: 1.25

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/clear-outcomes-trial-and-cardiovascular-outcomes/15283/

In this program, expert faculty discuss data presented at the 2023 ACC Congress in a concise, informative, on-demand format. This format extends the congress analysis to a broader audience with greater detail than what is available in abstracts. Rapid advances from the meeting require well-planned educational programming to bridge knowledge, competence, and performance gaps.

CME credits: 1.25

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/the-stellar-phase-3-trial-a-study-of-sotatercept-in-combination-with-background-therapy-for-the-treatment-of-pulmonary-arterial-hypertension/15282/

In this program, expert faculty discuss data presented at the 2023 ACC Congress in a concise, informative, on-demand format. This format extends the congress analysis to a broader audience with greater detail than what is available in abstracts. Rapid advances from the meeting require well-planned educational programming to bridge knowledge, competence, and performance gaps.

CME credits: 2.00

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/summing-up-echocardiography-risk-assessment-and-patient-monitoring-for-ph/15247/

This program increases clinician awareness of noninvasive diagnostic approaches (i.e., echocardiogram) and provides training tools for recognizing and interpreting high-risk features that can affect the diagnosis and treatment of patients with pulmonary hypertension (PH). The goal is to make an early and accurate diagnosis to prevent the progression of the disease to more advanced stages. Undiagnosed disease progression can delay initiation of potentially effective therapies and referral to PH centers, leading to more significant patient morbidity and mortality.

CME credits: 2.00

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/summing-up-essential-echo-imaging-structures-and-evaluation-for-ph/15246/

This program increases clinician awareness of noninvasive diagnostic approaches (i.e., echocardiogram) and provides training tools for recognizing and interpreting high-risk features that can affect the diagnosis and treatment of patients with pulmonary hypertension (PH). The goal is to make an early and accurate diagnosis to prevent the progression of the disease to more advanced stages. Undiagnosed disease progression can delay initiation of potentially effective therapies and referral to PH centers, leading to more significant patient morbidity and mortality.

CME credits: 2.00

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/the-echoright-smart-phone-app-emerging-tools-for-echocardiography-in-ph/15245/

This program increases clinician awareness of noninvasive diagnostic approaches (i.e., echocardiogram) and provides training tools for recognizing and interpreting high-risk features that can affect the diagnosis and treatment of patients with pulmonary hypertension (PH). The goal is to make an early and accurate diagnosis to prevent the progression of the disease to more advanced stages. Undiagnosed disease progression can delay initiation of potentially effective therapies and referral to PH centers, leading to more significant patient morbidity and mortality.

CME credits: 2.00

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/differentiating-group-1-from-group-2-ph-using-echo/15242/

This program increases clinician awareness of noninvasive diagnostic approaches (i.e., echocardiogram) and provides training tools for recognizing and interpreting high-risk features that can affect the diagnosis and treatment of patients with pulmonary hypertension (PH). The goal is to make an early and accurate diagnosis to prevent the progression of the disease to more advanced stages. Undiagnosed disease progression can delay initiation of potentially effective therapies and referral to PH centers, leading to more significant patient morbidity and mortality.

CME credits: 2.00

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/screening-for-pah-using-echo-detect-and-ssc-pah/15231/

This program increases clinician awareness of noninvasive diagnostic approaches (i.e., echocardiogram) and provides training tools for recognizing and interpreting high-risk features that can affect the diagnosis and treatment of patients with pulmonary hypertension (PH). The goal is to make an early and accurate diagnosis to prevent the progression of the disease to more advanced stages. Undiagnosed disease progression can delay initiation of potentially effective therapies and referral to PH centers, leading to more significant patient morbidity and mortality.

CME credits: 2.00

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/maximizing-echo-image-utility-for-ph-diagnosis/14717/

This program increases clinician awareness of noninvasive diagnostic approaches (i.e., echocardiogram) and provides training tools for recognizing and interpreting high-risk features that can affect the diagnosis and treatment of patients with pulmonary hypertension (PH). The goal is to make an early and accurate diagnosis to prevent the progression of the disease to more advanced stages. Undiagnosed disease progression can delay initiation of potentially effective therapies and referral to PH centers, leading to more significant patient morbidity and mortality.

CME credits: 2.00

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/essential-ph-imaging-techniques-and-views/14716/

This program increases clinician awareness of noninvasive diagnostic approaches (i.e., echocardiogram) and provides training tools for recognizing and interpreting high-risk features that can affect the diagnosis and treatment of patients with pulmonary hypertension (PH). The goal is to make an early and accurate diagnosis to prevent the progression of the disease to more advanced stages. Undiagnosed disease progression can delay initiation of potentially effective therapies and referral to PH centers, leading to more significant patient morbidity and mortality.

CME credits: 2.00

Valid until: 27-03-2024

Claim your CME credit at https://reachmd.com/programs/cme/why-is-it-critical-to-suspect-ph-in-your-patient-evaluation/14713/

This program increases clinician awareness of noninvasive diagnostic approaches (i.e., echocardiogram) and provides training tools for recognizing and interpreting high-risk features that can affect the diagnosis and treatment of patients with pulmonary hypertension (PH). The goal is to make an early and accurate diagnosis to prevent the progression of the disease to more advanced stages. Undiagnosed disease progression can delay initiation of potentially effective therapies and referral to PH centers, leading to more significant patient morbidity and mortality.